Literature DB >> 33940398

Associations of sarcopenic obesity versus sarcopenia alone with functionality.

Gulistan Bahat1, Cihan Kilic2, Serdar Ozkok2, Savas Ozturk3, Mehmet Akif Karan2.   

Abstract

BACKGROUND & AIMS: There have been several attempts to come up with a global operational definition of sarcopenia (S), and consequently, a definition of S has been established, to some extent. That said, the definition of sarcopenic obesity (SO), which is defined as the presence of obesity + sarcopenia, remains obscure, hindering evaluations of the prevalence and relevance of SO. It has yet to be elucidated whether SO is associated with worse functionality when compared to S alone (S without obesity). In the present study, we compare SO and S alone in terms of their associations with functional measures through the application of alternative definitions of SO. As a secondary output, we document the prevalence of SO based on alternative definitions.
METHODS: This retrospective cross-sectional study included community-dwelling adults over 60 years of age who presented as outpatients to a university hospital between 2012 and 2020. All were evaluated for body composition (bioimpedance analysis), handgrip strength (Jamar hand dynamometer) and functional health status [activities of daily living (ADL), instrumental activities of daily living (IADL)]. The fat percentile method was used to define the obesity component of SO. Low muscle mass (LMM) was defined using two different adjustment methods of skeletal muscle mass (LMM adjusted by height2 or LMM adjusted by BMI). S was defined based on the EWGSOP2 definition, as probable S (low muscle strength) or confirmed S (low muscle strength + LMM). Accordingly, three alternative definitions of SO were applied based on three alternative definitions of S, i.e., "obesity + sarcopenia (probable)", "obesity + sarcopenia (confirmed, LMM adjusted by height2)" and "obesity + sarcopenia (confirmed, LMM adjusted by BMI)". The associations of SO and S alone with functional measures were examined with univariate analyses and adjusted multivariate analyses.
RESULTS: Included in the study were 1468 older adults (median age 75; 68.8% female). The prevalence of SO was very low (0.2%) based on the SO definition "obesity + sarcopenia (confirmed, LMM adjusted by height2), but it was present at a considerable and comparable rate based on SO definition "obesity + sarcopenia (probable)" and SO definition "obesity + sarcopenia (confirmed, LMM adjusted by BMI)" (4.1%, 4.0%; respectively). As SO by "obesity + sarcopenia (confirmed, LMM adjusted by height2)" had an ignorable prevalence, this definition of SO was excluded from further analyses. Multivariate analyses revealed that, when compared to the Non-S Non-Obese group, S alone definitions had odds ratio (OR) of 5.4 and 3.4 while SO definitions had an OR of 3.2 and 2.7 for impaired ADL, and an OR of 7.9 and 6.4, while SO definitions had an OR of 3.0 and 2.7 for impaired IADL. SO was thus found to be associated with a lower prevalence of impaired functional measures than that of S alone.
CONCLUSIONS: Our results suggest that the SO definition confirmed, LMM adjusted by height2 has an ignorable prevalence in populations in which underweight or malnutrition is uncommon. Among sarcopenic older individuals, obesity may have a protective effect against the limitations of some functional measures, providing evidence of the possible protective effect of obesity in sarcopenic individuals.
Copyright © 2021 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  Definition; EWGSOP2; Fat percentile; Functionality; Sarcopenia; Sarcopenic obesity

Year:  2021        PMID: 33940398     DOI: 10.1016/j.clnu.2021.04.002

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  13 in total

Review 1.  The current situation in the approach to osteoporosis in older adults in Turkey: areas in need of improvement with a model for other populations.

Authors:  Gulistan Bahat; Nezahat Muge Catikkas; Dilek Gogas Yavuz; Pinar Borman; Rengin Guzel; Jean Yves Reginster
Journal:  Arch Osteoporos       Date:  2021-11-30       Impact factor: 2.617

2.  Sarcopenic obesity is associated with impaired physical function and mortality in older patients with heart failure: insight from FRAGILE-HF.

Authors:  Hiroshi Saito; Yuya Matsue; Kentaro Kamiya; Nobuyuki Kagiyama; Daichi Maeda; Yoshiko Endo; Hidenao Ueno; Kenji Yoshioka; Akira Mizukami; Kazuya Saito; Yuki Ogasahara; Emi Maekawa; Masaaki Konishi; Takeshi Kitai; Kentaro Iwata; Kentaro Jujo; Hiroshi Wada; Masaru Hiki; Taishi Dotare; Tsutomu Sunayama; Takatoshi Kasai; Hirofumi Nagamatsu; Tetsuya Ozawa; Katsuya Izawa; Shuhei Yamamoto; Naoki Aizawa; Kazuki Wakaume; Kazuhiro Oka; Shin-Ichi Momomura; Tohru Minamino
Journal:  BMC Geriatr       Date:  2022-07-05       Impact factor: 4.070

3.  Ishii test for screening sarcopenia: performance in community-dwelling older adults.

Authors:  Tugba Erdogan; Nezahat Muge Catikkas; Meryem Merve Oren; Cihan Kılıc; Mehmet Akif Karan; Gulistan Bahat
Journal:  Aging Clin Exp Res       Date:  2021-10-15       Impact factor: 4.481

4.  Prognostic Value of Isolated Sarcopenia or Malnutrition-Sarcopenia Syndrome for Clinical Outcomes in Hospitalized Patients.

Authors:  Iasmin Matias Sousa; Camila Ferri Burgel; Flávia Moraes Silva; Ana Paula Trussardi Fayh
Journal:  Nutrients       Date:  2022-05-26       Impact factor: 6.706

Review 5.  Multifactorial Mechanism of Sarcopenia and Sarcopenic Obesity. Role of Physical Exercise, Microbiota and Myokines.

Authors:  Jan Bilski; Piotr Pierzchalski; Marian Szczepanik; Joanna Bonior; Jerzy A Zoladz
Journal:  Cells       Date:  2022-01-04       Impact factor: 6.600

6.  Cut-off points to screening for sarcopenia in community-dwelling older people residents in Brazil.

Authors:  Sabrina Gabrielle Gomes Fernandes; Luiz Eduardo Lima de Andrade; Rafaella Silva Dos Santos Aguiar Gonçalves; Saionara Maria Aires da Câmara; Ricardo Oliveira Guerra; Alvaro Campos Cavalcanti Maciel
Journal:  PeerJ       Date:  2021-08-25       Impact factor: 2.984

7.  Sarcopenic obesity and therapeutic outcomes in gastrointestinal surgical oncology: A meta-analysis.

Authors:  Peiyu Wang; Shaodong Wang; Yi Ma; Haoran Li; Zheng Liu; Guihu Lin; Xiao Li; Fan Yang; Mantang Qiu
Journal:  Front Nutr       Date:  2022-07-22

8.  Growth Differentiation Factor-15 as a Biomarker for Sarcopenia in Patients With Chronic Obstructive Pulmonary Disease.

Authors:  Mingming Deng; Yiding Bian; Qin Zhang; Xiaoming Zhou; Gang Hou
Journal:  Front Nutr       Date:  2022-06-30

9.  Why should sarcopenic obesity be included in a routine assessment during weight-management programmes?

Authors:  Marwan El Ghoch; Massimo Pellegrini
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-22       Impact factor: 6.055

10.  Sarcopenia, Obesity, Sarcopenic Obesity and Risk of Poor Nutritional Status in Polish Community-Dwelling Older People Aged 60 Years and Over.

Authors:  Marika Murawiak; Roma Krzymińska-Siemaszko; Aleksandra Kaluźniak-Szymanowska; Marta Lewandowicz; Sławomir Tobis; Katarzyna Wieczorowska-Tobis; Ewa Deskur-Śmielecka
Journal:  Nutrients       Date:  2022-07-14       Impact factor: 6.706

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.